| Trial ID: | L1415 |
| Source ID: | NCT06193616
|
| Associated Drug: |
Octreotide
|
| Title: |
Outcome of ADPKD With Octreotide LAR
|
| Acronym: |
ADPKD648
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Autosomal Dominant Polycystic Kidney
|
| Interventions: |
DRUG: Octreotide
|
| Outcome Measures: |
Primary: GFR change over time, Assessed by six-monthly routine iohexol plasma clearance and annual TKV measurements, change from start (day 0) and month 6,12,18,24,30,36,42,48 |
|
| Sponsor/Collaborators: |
Sponsor: Mario Negri Institute for Pharmacological Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
70
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2024-02-12
|
| Completion Date: |
2024-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-03-15
|
| Locations: |
ASST HPG23 - Unità di Nefrologia, Bergamo, BG, 24100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT06193616
|
